News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
New Corin Group plc (US Headquarters) Hip System Wins Nod From FDA Experts; Shares Soar
February 23, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (CNNMoney.com) -- FDA advisors gave their nod to a new hip resurfacing system from the British company Corin, placing it one step closer to regulatory approval.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Adcomms
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
May 22, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA Asks Pfizer/BioNTech, Moderna To Add Myocarditis Risk to COVID-19 Vaccines
May 22, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
May 21, 2025
·
2 min read
·
Dan Samorodnitsky
Lymphoma
Roche’s Genentech Fails to Win Adcomm Backing for Columvi Expansion
May 21, 2025
·
2 min read
·
Tristan Manalac